Symbol="ADPT"
AssetType="Common Stock"
Name="Adaptive Biotechnologies Corp"
Description="Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company is headquartered in Seattle, Washington."
CIK="1478320"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="1551 EASTLAKE AVENUE EAST SUITE 200, SEATTLE, WA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="909159000"
EBITDA="-166283008"
PERatio="None"
PEGRatio="0"
BookValue="2.738"
DividendPerShare="0"
DividendYield="0"
EPS="-1.37"
RevenuePerShareTTM="1.321"
ProfitMargin="-1.007"
OperatingMarginTTM="-0.992"
ReturnOnAssetsTTM="-0.15"
ReturnOnEquityTTM="-0.418"
RevenueTTM="189601000"
GrossProfitTTM="-13657000"
DilutedEPSTTM="-1.37"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.121"
AnalystTargetPrice="11.88"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="6.64"
PriceToBookRatio="2.436"
EVToRevenue="4.698"
EVToEBITDA="-3.906"
Beta="1.179"
num_52WeekHigh="12.58"
num_52WeekLow="5.96"
num_50DayMovingAverage="7.37"
num_200DayMovingAverage="7.99"
SharesOutstanding="144311000"
DividendDate="None"
ExDividendDate="None"
symbol="ADPT"
open="6.34"
high="6.45"
low="6.19"
price="6.30"
volume="1084648.00"
latest_trading_day="2023-08-11"
previous_close="6.42"
change="-0.12"
change_percent="-1.8692%"
aroon_positive_momentum_days="52"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="52"
Volume_recent_avg="1002912"
Change_recent_avg="-0.02"
Delta_recent_avg="0.44"
Variance_recent_avg="0.22"
Change_ratio_recent_avg="-0.41"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="52"
Aroon_momentum_negative="48"
image_negative_thumbnail_id_1="1123"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0156.jpeg"
image_negative_thumbnail_id_2="490"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0115.jpeg"
image_neutral_thumbnail_id_1="588"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0011.jpeg"
image_neutral_thumbnail_id_2="591"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0008.jpeg"
image_positive_thumbnail_id_1="990"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0152.jpeg"
image_positive_thumbnail_id_2="997"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0159.jpeg"
image_professor_thumbnail_id_1="1169"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
image_professor_thumbnail_id_2="1196"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
